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Abstract
Background: No previous studies have created and validated prediction models for outcomes in patients receiving
spinal manipulation for care of chronic low back pain (cLBP). We therefore conducted a secondary analysis
alongside a dose-response, randomized controlled trial of spinal manipulation.
Methods: We investigated dose, pain and disability, sociodemographics, general health, psychosocial measures,
and objective exam findings as potential predictors of pain outcomes utilizing 400 participants from a randomized
controlled trial. Participants received 18 sessions of treatment over 6-weeks and were followed for a year. Spinal
manipulation was performed by a chiropractor at 0, 6, 12, or 18 visits (dose), with a light-massage control at all
remaining visits. Pain intensity was evaluated with the modified von Korff pain scale (0–100). Predictor variables
evaluated came from several domains: condition-specific pain and disability, sociodemographics, general health status,
psychosocial, and objective physical measures. Three-quarters of cases (training-set) were used to develop 4
longitudinal models with forward selection to predict individual “responders” (≥50 % improvement from baseline) and
future pain intensity using either pretreatment characteristics or post-treatment variables collected shortly after
completion of care. The internal validity of the predictor models were then evaluated on the remaining 25 % of cases
(test-set) using area under the receiver operating curve (AUC), R2, and root mean squared error (RMSE).
Results: The pretreatment responder model performed no better than chance in identifying participants who became
responders (AUC = 0.479). Similarly, the pretreatment pain intensity model predicted future pain intensity poorly with
low proportion of variance explained (R2 = .065). The post-treatment predictor models performed better with AUC = 0.665
for the responder model and R2 = 0.261 for the future pain model. Post-treatment pain alone actually predicted future
pain better than the full post-treatment predictor model (R2 = 0.350). The prediction errors (RMSE) were large (19.4 and
17.5 for the pre- and post-treatment predictor models, respectively).
Conclusions: Internal validation of prediction models showed that participant characteristics preceding the start of care
were poor predictors of at least 50 % improvement and the individual’s future pain intensity. Pain collected shortly after
completion of 6 weeks of study intervention predicted future pain the best.
Keywords: Chronic low back pain, Prediction model, Spinal manipulation, Chiropractic, Dose–response, Randomized
controlled trial
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Background
The most common cause of disability is low back pain
with an estimated 1099 years of life lost to disability each
year per 100,000 people, worldwide, in 2010 [1]. The
prevalence of chronic low back pain (cLBP) is approxi-
mately 10 % [1, 2]. An effective approach to treating low
back pain can include spinal manipulative therapy (SMT)
[3–5]. Advantageously, treatment of cLBP with spinal ma-
nipulative therapy does not appear to increase the cost of
treatment plus lost productivity [6]. The question remains
though, about what kind of patient has a greater chance of
benefit with efficacious conservative therapies such as SMT
[7–9], mechanical lumbar traction [10], and a stabilization
exercise program [11]. Our study is a step in this direction
and to our knowledge, this is the only study to date that
has sought to create prediction models of prognosis in indi-
viduals receiving a dose of SMT for the care of cLBP. This
scientific inquiry is of great societal interest given today’s
environment of prevention of opiate deaths in chronic pain
management [12–16].
There have been few studies evaluating determinants
of outcomes in patients receiving SMT for the care of
cLBP. Leboeuf-Yde et al., [17] looked at predictors in a
cohort of chiropractic patients with persistent low back
pain. They found sex, social benefit, severity of pain,
duration of continuous pain at first consultation, and
additional neck pain predictive of failure to recover in
the short term. Most notable was being pain-free at the
fourth visit was a strong predictor of recovery at 3 and
12 months. Dougherty et al. [18] modified the clinical
prediction rule developed by Flynn et al. [7] so it could
be tested in a randomized trial in a chronic patient
population. The modified rule was not successful, a cau-
tionary tale against using a prediction rule in individuals
for which it was not specifically developed. A large
practice-based observational study reported in Nyiendo
et al.[8] and Haas et al. [9] found the following to be
predictive of outcomes: baseline pain and disability, age,
history of low back pain, duration of baseline LBP epi-
sode, pain below the knee, provider type, income, smok-
ing, comorbidity, and chronic depression.
The aim of this secondary analysis was to build and
attempt to internally validate prediction models for pain
outcomes in cLBP patients treated with SMT in a random-
ized controlled trial. The purpose was prognosis related to
a course of care, rather than development of a clinical pre-
diction rule for selecting from among alternative interven-
tions. Models were created separately using data from the
two most natural time points for discussing prognosis with
a patient in clinical practice: immediately prior to care (pre-
treatment predictor models) and following completion of
care (post-treatment predictor models). The two outcomes
that were predicted by the models were the continuous
pain score and a dichotomous responder indicator (50 % or
greater improvement in pain score from the baseline). Our
approach was unique for studies of SMT in that the sample
was partitioned to both create and test the strength of the
prediction models in one study.
Methods
Design
Data were obtained through a randomized clinical trial
looking for the dose effect of spinal manipulative therapy
for cLBP [3, 6]. Four hundred participants were random-
ized to 4 dose groups, 100 patients per group. Partici-
pants were treated 3 times per week for 6 weeks. They
received 0, 1, 2, or 3 SMT sessions per week (0, 6, 12, or
18 total SMT visits) with control visits, consisting of
light massage, on non-manipulation visits. All care was
provided in the Portland metro area. Outcomes were
collected at baseline and 6, 12, 18, 24, 39, and 52 weeks
after randomization on. Randomization coincided with
the first treatment visit.
Participants
All patients provided informed consent for participation
in this study which was approved of by University of
Western States Institutional Review Board. Patients were
recruited through craigslist, mailers, and newspaper
advertisements in the Portland Metro area to participate
in our study. Details on subject enrollment, inclusion/
exclusion criteria, design, and analysis are reported else-
where [3]. Details on cost effectiveness and the doctor/
patient interaction have also been reported [6, 19].
Patients were considered chronic if their low back pain
was at least 3 months in duration and they had at least
30 days of low back pain in the last 6 weeks. A minimum
pain score of 25 (0–100 scale) was required in order to
prevent floor effects. Participants were excluded for
contraindications to SMT, such as active cancer, spine
pathology, inflammatory arthropathies, autoimmune
disorders, and anti-coagulant conditions. Also excluded
were those with potential confounders to pain and disability
improvement; including neurodegenerative diseases, pain
radiating below the knee, organic referred pain, and
disability compensation [3].
Intervention
The intervention was SMT consisting of manual high
velocity, low amplitude, thrust spinal manipulation [20].
The control appointments consisted of a brief light mas-
sage, shorter and lighter than what would be considered
appropriate in a therapeutic massage practice [21, 22].
In addition to SMT or light massage, at each visit, all
participants received 5 min of hot pack treatment to
relax the back musculature and 5 min of very low inten-
sity pulsed ultrasound (0.5 watts/cm2) to enhance cred-
ibility of care. This was deemed necessary for fidelity of
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care in patients receiving only or mostly a brief light
massage.
Pain and disability scales
We assessed cLBP with the modified Von Korff pain and
disability scales, validated by Underwood et al. [23]. The
pain scale consisted of asking patients to rate their pain
today, average pain over the last four weeks, and worst
pain over the past 4 weeks each on a 0–10 pain scale
with no pain and as bad as pain could be as the anchors.
The disability scale consisted of asking patients to rate
how much their low back pain interfered with their daily
activities; changed their ability to take part in recre-
ational, social, and family activities; and changed their
ability to work (including house and yard work) with no
interference/change and extreme interference/change as
the anchors. For both pain and disability, the 3 0–10
scales were averaged and then multiplied by 10 to create
the two modified Von Korff scores on 0 to 100 scales.
Outcome measures
Pain intensity was measured by the Modified Von Korff
pain scale described above [23]. Pain outcomes were ana-
lyzed either as a continuous score (future pain intensity)
or as a binary indicator for a responder. Choosing a di-
chotomous responder indicator is recommended by the
NIH Task Force for Research Standards on Chronic Low
Back Pain [24]. For a given follow-up visit, a responder
was defined as having at least 50 % improvement relative
to the baseline pain intensity [24, 25]. Fifty percent im-
provement in back pain is considered substantial [26].
Note that the same participant could be classified as a re-
sponder during one visit and not at another. The pretreat-
ment predictor models were used to predict the outcomes
at the 6, 12, 18, 24, 39 and 52-week follow-ups and the
post-treatment predictor models were used to predict the
outcomes at the 12, 18, 24, 39 and 52-week follow-ups.
Predictive measures
A more extensive discussion of the outcomes used in
this study is provided in our paper on main results from
our dose response study [3]. Potential pretreatment pre-
dictors were collected at baseline by questionnaire
(Table 1). Demographics included age, gender, education,
race, and ethnicity. Validated low back pain characteris-
tics were the primary outcomes, pain intensity and dis-
ability [23], as well as pain unpleasantness [27]. Other
common condition-specific variables we have used in
the past were days with pain, days with disability, duration,
and previous treatment [28, 29]. General Health status
measures were comorbidity, smoking, and the validated
EuroQol-5D [30–32] and SF-12 [33, 34]. Psychosocial vari-
ables were the Fear Avoidance Beliefs Questionnaire [35]
and previously used confidence in the success of SMT and
light massage [28, 29]. Dose was determined during
randomization at baseline and coded as 0, 1, 2, or 3 repre-
senting the multiple of 6 SMT sessions each study group
received. Follow-up time point was used as a continuous
variable measured in weeks from randomization.
Objective physical exam measures included lumbar
range of motion, segmental hypomobility, and pain pres-
sure threshold. Lumbar range of motion was measured
in flexion , extension, and lateral bending [36–38]; reli-
ability has been established by Keeley et al. [39]. The
accompanying self-reported pain was evaluated using
the validated 0 to 10 numeric pain rating scale [40]. The
sum of these pain scores, the difference between right
and left lateral bending pain scores, and maximum pain
score were also of interest for prediction model develop-
ment. A modified Schober test [41, 42] was conducted on
each patient; test reliability has been established [43–45].
Segmental hypomobility from L1 through L5 was deter-
mined by manual motion palpation [46, 47] and defined
for this study as restriction of motion in any plane of
motion. The total number of hypomobile joints were
also recorded [46, 47]. Stochkendahl et al. [47]
recently observed that global assessment of hypomobi-
lity has clinically acceptable reproducibility. Pain
pressure thresholds (PPT) were assessed from L1
through S1 using a validated pressure algometer
[48, 49].
Potential post-treatment predictors were collected sev-
eral days after the end of treatment (6 weeks after
randomization) and included pain intensity, disability,
LBP unpleasantness, days with LBP, days with disability
due to LBP, satisfaction with care [8, 19, 50, 51] and ob-
jective physical exam measures, as well as dose and time
(follow-up time points listed under outcome measures).
Analysis
The data set was randomly split into two sets. The train-
ing set included all data for 75 % of the participants and
the test set included all data for the remaining 25 % of
the participants. The multivariate prediction models
were developed on the training-set and the ability of the
developed models to predict the outcomes was evaluated
on the test set. This random split enabled internal valid-
ation of the developed model in the same study and
addressed the potential issue of over-optimism (over-fitting)
of the model in the training set.
For each of the 2 outcomes, we developed a pretreat-
ment and a post-treatment predictor model using the
variables identified above. The outcomes were modeled
by logistic regression (responder outcome) and linear
regression (future pain intensity outcome) using general-
ized estimating equations (with the AR1 correlation
structure) to account for the repeated measures for the
same subject [52–54]. Analysis included all time points
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Dose (per 6 spinal manipulation visits) † †
Time (in weeks
Pain/Disability
Pain intensity (0–100 scale) 51.6 (17.2) †
Functional disability (0–100) 45.3 (22.7) †
Pain unpleasantness (0–100) 41.4 (21.4) †
Days with pain (last 4 wk) 24.1 ( 5.2) †
Days with disability (last 4 wk) 6.8 ( 7.6) †
Duration (yr) 11.8 ( 9.8)
Sociodemographics
Age (yr) 41.3 (14.1)
Female, % (n) 50 % (196)
Non-white or Hispanic, % (n) 15 % (58)
College degree, % (n) 56 % (219)
Income $40 K or less, % (n) 57 % (222)
General Health
Comorbidities (#) 0.9 ( 1.1) †
Smoking, % (n) 11 % (43)
SF-12 physical health componentb 43.3 ( 8.9) †
SF-12 mental health componentb 48.9 (10.5)
EuroQol – VAS (0–100 visual analog scale) 70.9 (15.8) † †
EuroQol 5D – mobility (1–3) 1.4 ( 0.5) †
EuroQol 5D – self-care (1–3) 1.2 ( 0.4) † †
EuroQol 5D – usual activities (1–3) 1.7 ( 0.5) †
EuroQol 5D – pain (1–3) 2.0 ( 0.2) †
EuroQol 5D – anxiety/depression (1–3) 1.4 ( 0.5) †
Psychosocial
FABQ Work beliefs (0–100) 32.9 (21.8) †
FABQ Activity beliefs (0–100) 56.0 (20.3) †
Confidence in treatment success (−6 - +6) 0.2 ( 0.8)
Objective Physical Exam c
Lumbar ROM: flexion 43.2 (16.3)
Lumbar ROM: extension 15.1 (10.2)
Lumbar ROM: right lateral bending 18.6 ( 9.4)
Lumbar ROM: left lateral bending 19.1 ( 8.9)
LBP: Flexion (0–10) 2.3 ( 2.4) † †
LBP: Extension (0–10) 3.0 ( 2.4) †
LBP: Right lateral bending (0–10) 2.7 ( 2.4) † †
LBP: Left lateral bending (0–10) 2.6 ( 2.3) † †
LBP: sum for 4 lumbar ROM 0–10 pain scores 10.7 ( 7.9) † †
LBP: maximum of 4 lumbar ROM pain scores 4.0 ( 2.3) †
LBP: right – left lateral bending 0.1 ( 1.9)
LBP: |right – left lateral bending| 1.2 ( 1.5)
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in aggregate (as repeated measures) to improve the sta-
bility and power of the estimated model and to avoid the
complexity of reporting and interpreting results from
separate predictor models for each time point. A sensi-
tivity analysis (not shown) of models for individual time
points showed results that were consistent with and war-
ranting the repeated-measures analysis.
Model development
The prediction models were developed in 2 steps. First,
a univariate analysis was performed on the set of all po-
tential predictors with treatment dose forced into all
models (to adjust for the primary purpose of the trial
which was to evaluate the effect of dose). Second, statis-
tically significant variables (p < .05) in the univariate ana-
lysis were then considered for inclusion into the
multivariate models. The multivariate predictor models
used a forward stepwise variable selection procedure
with p < .05 required for entry into the model [55]. Ob-
servations with missing data were dropped.
For the responder models (binary data outcome), the
odds ratio, 95 % confidence intervals, and p-values are
reported. The odds ratio gives the increase in the odds
of being a responder after adjusting for the other vari-
ables in the model. For the future pain intensity models
(continuous data outcome), linear regression coefficients
(β), 95 % confidence intervals, and p-values are reported.
The coefficient β estimates the change in mean future
pain intensity score expected for a unit change of the
predictor variable after controlling for the other vari-
ables in the predictor model.
Model evaluation
The predictive ability of the models in the training and
test sets are expressed by the area under receiver operat-
ing characteristics curve (AUC) for the binary responder
models [56] and by both root mean square error (RMSE)
and R2 for the continuous future pain intensity models
[57]. The AUC measures the ability to predict a binary
outcome on a 0 to 1 scale with AUC = 0.50 representing
prediction expected by chance alone and AUC = 1 repre-
senting perfect prediction. The RMSE estimates the
standard deviation of the prediction error, which is de-
fined as the difference between the predicted and ob-
served future pain scores. R2 is the proportion of the
variation in the continuous outcome explained by the
model.
Of 400 participants, the 391 who provided follow-up
data were included in the analysis for the pretreatment
models, while 385 with follow-up data were included in
the post-treatment models. Follow-up missing data were
Table 1 Pretreatment characteristics and univariate pain prediction modelsa (Continued)
LBP: sum for right and left lateral bending pain scores 5.3 ( 4.3) † †
LBP: maximum of right and left lateral bending pain scores 3.2 ( 2.4) † †
Modified Schober Test (cm) 5.7 ( 2.0)
Lumbar hypomobility: L1, % (n) 54 % (209) †
Lumbar hypomobility: L2, % (n) 52 % (200)
Lumbar hypomobility: L3, % (n) 49 % (189)
Lumbar hypomobility: L4, % (n) 49 % (191)
Lumbar hypomobility: L5, % (n) 64 % (248)
Total hypomobile joints: L1 thru L5 2.7 ( 1.3)
Pain Pressure Threshold: right L1-L2 6.1 ( 2.8)
Pain Pressure Threshold: left L1-L2 6.2 ( 2.9)
Pain Pressure Threshold: right L3-L4 5.9 ( 3.0)
Pain Pressure Threshold: left L3-L4 6.0 ( 3.2)
Pain Pressure Threshold: right L5-S1 5.8 ( 3.2) †
Pain Pressure Threshold: left L5-S1 5.7 ( 3.3) †
Pain Pressure Threshold: minimum of 6 measures 4.5 ( 2.5) †
OR Odds ratio, r Pearson’s correlation coefficient, β regression coefficient, VAS visual analog scale, FABQ fear avoidance beliefs questionnaire, ROM range of
motion, LBP low back pain
†Variables with a statistically significant association with outcome, p-value < 0.05, after adjusting for dose
aLogistic and linear longitudinal regressions were adjusted for dose and were fitted using generalized estimating equations to account for correlation across time
points. Only the statistically significant variables (p < .05) in this table are used as candidates for the subsequent inclusion into the relevant final multivariate
prediction models
bScores are standardized to the US general population (mean = 50, SD = 10)
cROM was measured in degrees, LBP during ROM on a 0 to 10 scale for each of the 4 ROMs, and pain pressure threshold in kg. Hypomobility was identified using
manual motion palpation
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imputed for these intention-to-treat analyses using linear
interpolation and last point carried forward.
Analyses were conducted with Stata 11.0 (StataCorp,
College Station, TX) and R version 3.1.0 (R Foundation
for Statistical Computing, Vienna, Austria). All tests
were two-sided and p < 0.05 was used to denote statis-
tical significance. Multiple testing adjustments were not
made because this was an exploratory analysis aimed at
evaluating the feasibility of prediction.
Results
Pretreatment variables
Table 1 shows the descriptive statistics for the baseline
variables that were considered for entry into pretreat-
ment predictor models. On average, these patients were
41 years old, equally split in gender, and white non-
Hispanic; they had moderate pain (52/100) and disability
(45/100), chronic back pain of about 12 years in dur-
ation, moderate baseline health, previous care for their
back problems, and confidence in success of study care
[3]. Mean global lumbar range of motion was 43° flexion,
15° extension, and 19° lateral bending. Overall, reported
pain with lumbar motion was mild to moderate (3/10).
Pain pressure thresholds were reported to be about
6 kg/cm2 from L1 through L5, on average. Table 1 also
notes the statistically significant variables in the univari-
ate analyses (p < .05) that were considered for inclusion
into the multivariate models.
There were no missing values in the variables consid-
ered in the responder multivariate model and <2 % miss-
ing values for variables considered in the multivariate
model for future pain intensity. Less than <3 % of values
were missing for the remaining variables. In aggregate,
only 2.6 % observations had to be dropped due to miss-
ing values in variables for building the multivariate
model for future pain intensity.
Pretreatment multivariate predictor models
The predictive ability of the pretreatment responder model
in the training and test sets were quantified by the AUC
statistic and illustrated visually by the receiver operating
characteristics (ROC) curves (Table 2 and Fig. 1). While the
model appeared to predict some risk of being a responder
in the training set (AUC= 0.624), in the test set the model
performed similarly to chance only (AUC= 0.479 vs. 0.500
for chance). Among the variables selected into the model,
greater odds of 50 % improvement in pain were associated
with greater dose of SMT, while poorer odds were associ-
ated with comorbidity, less tendency towards self-care, and
greater pain with lumbar motion.
The ability to predict future pain intensity was also poor
(Table 2 and Fig. 2). The model R2 was 0.268 for the train-
ing set and 0.065 for the test set. Hence, the model could
account for only a trivial percentage of the variability in
future pain. The prediction error (RMSE) was large for both
the training and test set data (RMSE = 17.4 and 19.4 points,
Table 2 Final multivariate pretreatment pain-prediction models and performance metricsa
Responders (N = 297/94)b Future pain intensity (N = 289/94)b
Independent variables OR (95 % CI) P-value β (95 % CI) P-value
Dose (per 6 spinal manipulation visits) 1.27 (1.08, 1.49) 0.004 −1.86 (−3.35, −0.38) 0.014
Pain/Disability
Pain intensity 4.77 (1.85, 7.70) 0.001
Pain unpleasantness 3.29 (0.35, 6.24) 0.028
General Health
Comorbidities 0.81 (0.67, 0.97) 0.025
EuroQol – VAS −2.20 (−4.00, −0.39) 0.017
EuroQol 5D – self-care (1–3) 0.64 (0.41, 0.99) 0.044
Objective Physical Exam
LBP: sum for 4 lumbar ROM pain scores 0.81 (0.67, 0.97) 0.024 2.89 (0.61, 5.16) 0.013
Performance metricsc AUC (95 % CI) RMSE (95 % CI) R2 (95 % CI)
Training set 0.624 17.4 .268
Test set 0.479 (0.387, 0.575) 19.4 (17.0, 21.6) .065 (−10.5, 21.9)
OR Odds ratio, PC part correlation, β regression coefficient, VAS visual analogue scale, AUC Area under the curve (receiver operating characteristic curve), RMSE
root mean squared error (SD of prediction error), R2 coefficient of determination, LBP low back pain
aVariables were selected into the regression models using forward selection among variables with p < .05 in the univariate analysis; dose was forced into the
models. Independent variables were standardized except for dose (scale unit = 6 visits) and self-care (scale unit = 1 on a 1–3 scale). Lower scores were favorable
for pain and self-care; higher scores for EuroQol VAS
bThe first number is the sample size for the model in the training set and the second number is the N for the test set
cChance performance is indicated by 0.5 for AUC. RMSE is the standard deviation of the error in prediction of future pain intensity evaluated on the 0 – 100 pain
scale. R2 is the proportion of the variance in pain intensity explained by the independent variables in the model. Confidence intervals for the performance metrics
are given for the test set only
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respectively). Predictors in the model associated with
greater future pain were greater baseline pain intensity and
unpleasantness, as well as greater pain with lumbar motion;
less future pain was related to greater dose of SMT and
greater general health evaluated with the EuroQol visual
analogue scale.
Post-treatment variables
Patient characteristics evaluated within several days after
completion of care (Table 3) show that, on average,
patients were in mild to moderate pain (31/100) and dis-
ability (28/100). Patients generally agreed or strongly
agreed, on average, that they were satisfied with care.
Patient perception of provider confidence in treatment
was more neutral because the study doctors were trained
to show equipoise with regards to study interventions.
Lumbar global range of motion increased only about 2°,
on average, in each direction. Overall, patients had
greater pain pressure thresholds than at baseline.
There were no missing values in most variables con-
sidered in the post-treatment multivariate models and
for those with missing values 8 % or fewer were missing.
In aggregate a total of 13.8 and 9.2 % of observations
had to be dropped due to missing values for building the
multivariate model for responders and for future pain
intensity, respectively.
Post-treatment multivariate predictor models
For responder prediction, AUC was 0.750 in the training
set and 0.665 for the test set (Table 4, Fig. 3). Greater
odds of 50 % improvement in pain intensity were associ-
ated with greater dose of SMT and the passage of time.
Poorer odds were associated with greater pain intensity,
Fig. 1 Pretreatment model ROC curves. Receiver operating characteristic (ROC) curves for the final multivariate model for prediction of responders. The
area under the curve (AUC) was 0.624 in the training set and 0.479 in the test set. Chance is shown by the diagonal line indicating AUC = 0.5
Fig. 2 Pretreatment model scatterplots. Observed pain scores are plotted against predicted pain scores from the final multivariate model for prediction of
follow-up pain. The diagonal line perfect agreement between predicted and observed values is shown for reference
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Table 3 Post-treatment (6-week) characteristics and univariate pain-prediction modelsa
Post-treatment (six-week) variables Post-treatment Mean (SD)
(N = 385)
Responder models Future pain intensity
models
Dose (per 6 spinal manipulation visits)
Time (in weeks)
Pain/Disability (6wk)
Pain intensity (0–100) 30.9 (17.2) † †
Functional disability (0–100) 27.7 (20.1) † †
Perceived change in pain (1–6) 4.2 (0.9) † †
Perceived change in pain score (−100 to 100) −38.3 (33.0) † †
Perceived change in disability (1–6) 3.9 (0.9) † †
Number of outside care visits prior 4 weeks 0.1 (1.3) †
Pain unpleasantness (0–100 scale) 19.6 (18.9) † †
Days with pain (last 4 wk) 16.9 (10.5) † †
Days with disability (last 4 wk) 1.6 ( 3.8) †
Psychosocial (6wk)
Satisfaction with chiropractor’s time listening (1–5) 4.7 ( 0.7) † †
Satisfaction with chiropractor’s comfort treating LBP (1–5) 4.8 ( 0.5) †
Satisfaction with chiropractor’s enthusiasm for treatment (1–5) 4.5 ( 0.8) †
Satisfaction with chiropractor’s confidence in treatment (1–5) 3.5 ( 1.0) † †
Mean satisfaction with chiropractor (1–5) 4.4 ( 0.5) † †
Confidence treatment is working (1–7) 4.9 ( 1.7) † †
Objective Physical Exam (6wk)b
Lumbar ROM: flexion 45.5 (17.6)
Lumbar ROM: extension 17.0 ( 9.5)
Lumbar ROM: right lateral bending 20.9 ( 9.7)
Lumbar ROM: left lateral bending 20.5 ( 9.6)
LBP: flexion (0–10) 1.1 ( 1.8) † †
LBP: extension (0–10) 1.7 ( 2.0) † †
LBP: right lateral bending (0–10) 1.4 ( 1.9) † †
LBP: left lateral bending (0–10) 1.3 ( 1.7) † †
LBP: sum for 4 lumbar ROMs pain scores (each 0–10) 5.4 ( 6.1) † †
LBP: maximum of 4 lumbar ROMs pain scores 2.5 ( 2.2) † †
LBP: right – left lateral bending 0.1 ( 1.4) † †
LBP: |right – left lateral bending| 0.8 ( 1.2) † †
LBP: sum for right and left lateral bending pain scores 2.7 ( 3.4) † †
LBP: maximum of right and left lateral bending pain scores 1.7 ( 2.0) † †
Modified Schober Test (cm) 21.0 ( 1.9)
Lumbar hypomobility: L1 % (n) 43 % (157)
Lumbar hypomobility: L2 % (n) 38 % (138)
Lumbar hypomobility: L3 % (n) 27 % (100)
Lumbar hypomobility: L4, % (n) 29 % (104) † †
Lumbar hypomobility: L5, % (n) 43 % (155) † †
Total hypomobile joints: L1 thru L5 1.8 ( 1.3) † †
Pain Pressure Threshold: right L1-L2 6.8 ( 3.7)
Pain Pressure Threshold: left L1-L2 6.8 ( 3.0) †
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days with pain, and difference in pain with left and right
lateral bending.
The ability to predict future pain in the study popula-
tion can be considered moderate with an R2 of 0.366 for
the training set and 0.261 for the test set. (Table 4,
Fig. 4). However, the RMSE was fairly large, 16.3 points
in the training set and 17.5 points in the test set. Greater
future pain intensity was related to greater 6-week pain
intensity and pain in right lateral bending.
In addition, we would like to point out that the 6-week
pain intensity predictor alone had better ability to predict
future pain score (R2 = 0.350 in the test set) compared to
the full multivariate predictor model (R2 = 0.261 in the test
set). The RMSE for the 6-week pain intensity only model
was 16.5 points for the training set and 17.6 points for the
test set, almost identical to the RMSE for the full multivari-
ate model.
Discussion
Our analysis demonstrates the importance of full in-
ternal validation using an independent data set. The dif-
ferences between the training set and test set in AUC
and R2 clearly illustrate the problem of over-optimism
(i.e., over-fitting) during model development (Tables 2
and 4) [58]. Whereas the performance of the pretreat-
ment model to predict responders and future pain inten-
sity might be considered promising in the training data
set, the internal validation of the model in the test set
showed failure to identify responders better than chance
and failure to explain variation in pain intensity after
baseline. For the post-treatment predictor models, per-
formance during internal validation was not as strong as
during model development, but still demonstrated some
ability to predict both responders and future pain
intensity.
Table 3 Post-treatment (6-week) characteristics and univariate pain-prediction modelsa (Continued)
Pain Pressure Threshold: right L3-L4 6.7 ( 3.3) †
Pain Pressure Threshold: left L3-L4 6.8 ( 3.2) †
Pain Pressure Threshold: right L5-S1 6.7 ( 3.4) †
Pain Pressure Threshold: left L5-S1 6.8 ( 3.5) †
Pain Pressure Threshold: minimum of 6 measures 5.4 ( 2.7) †
OR Odds ratio, r Pearson’s correlation coefficient, β regression coefficient, ROM range of motion, LBP low back pain
†Variables with a statistically significant association with outcome, p-value < 0.05, after adjusting for dose
aLogistic and longitudinal linear regressions were adjusted for dose and were fitted using generalized estimating equations to account for correlation across time
points. Only the statistically significant variables (p < .05) \in this table are used as candidates for the subsequent inclusion into the relevant final multivariate
prediction models
bROM was measured in degrees, LBP during ROM on a 0 to 10 scale for each of the 4 ROMs, and pain pressure threshold in kg. Hypomobility was identified using
manual motion palpation
Table 4 Final multivariate post-treatment pain-prediction models and performance metricsa
Responders (N = 249/93)b Future pain intensity (N = 262/93)b
Independent variables OR (95 % CI) P-value β (95 % CI) P-value
Dose (per 6 spinal manipulation visits) 1.14 (0.95, 1.37) 0.150 −0.07 (−1.35, 1.21) 0.910
Time (in weeks) 1.08 (1.02, 1.14) 0.004
Pain/Disability
Pain intensity 0.64 (0.51, 0.80) <0.001 10.7 (8.84, 12.56) <0.001
Days with pain (last 4 weeks) 0.57 (0.46, 0.70) <0.001
Objective Physical Exam
LBP: right – left lateral bending 0.76 (0.63, 0.92) 0.005
LBP: right lateral bending 2.95 (1.21, 4.69) 0.001
Performance metricsc AUC (95 % CI) RMSE (95 % CI) R2 (95 % CI)
Training set 0.750 16.3 .366
Test set 0.665 (0.58, 0.74) 17.5 (15.0, 20.1) .261 (7.5, 43.2)
OR Odds ratio, PC part correlation, β regression coefficient, ROM range of motion, AUC Area under the curve (receiver operating characteristic curve), RMSE root
mean squared error (SD of prediction error), R2 coefficient of determination, LBP low back pain
aVariables were selected into the regression models using forward selection among variables with p < .05 in the univariate analysis; dose was forced into the
models. Independent variables were standardized except for dose (scale unit = 6 visits) and time (scale unit = 1 week). Lower scores were favorable for pain and
days with pain
bThe first number is the sample size for the model in the training set and the second number is the N for the test set
cChance performance is indicated by 0.5 for AUC. RMSE is the standard deviation of the error in prediction of future pain intensity evaluated on the 0 – 100 pain
scale. R2 is the proportion of the variance in pain intensity explained by the independent variables in the model. Confidence intervals are given for the test
set only
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A desirable feature for clinical practice is the simplicity
of a prediction model. In our models, post-treatment
pain intensity alone predicted future pain intensity as
well as or better than the post-treatment model built
using many more predictor variables. The predictive
ability of the single variable model also did not decrease
as drastically between the training and test sets as the
predictive ability of the multivariate model. This reflects
the fact that fitting a model to a single variable does not
result in as much over-optimism (over-fitting) as building
a multivariate model using a large number of predictors.
The sustained predictive ability of the post-treatment,
pain-intensity-only model suggests that this variable is
very likely a true predictor of future pain and would very
likely be predictive of pain intensity in further studies car-
ried out in similar populations.
In our study, participants were treated for 18 visits over
six weeks. Timelines of treatment vary across different pre-
dictive studies. For example, the Nordic Back Pain study
only looked at patients for the first four visits over an
unspecified period of time [59, 60]. They also looked at
patients with and without sciatica while we excluded people
with pain below the knee; and they looked at daily versus
intermittent pain which we did not. Of the predictors in
their initial model, only increased pain also predicted a
worse prognosis in our model. LeBoeuf-Yde et al. [17]
found that early recovery was a strong predictor for
12 month recovery. This matches our findings that those
with less pain at the end of care were more likely to have
successful treatment over the rest of the year. However,
Leboeuf-Yde et al. had no test set and it is difficult to tell if
their model would hold in a similar population.
Fig. 3 Post-treatment model ROC curves. Receiver operating characteristic (ROC) curves for the final multivariate model for prediction of responders. The
area under the curve (AUC) was 0.750 in the training set and 0.665 in the test set. Chance is shown by the diagonal line indicating AUC = 0.5
Fig. 4 Post-treatment model scatterplots. Observed pain scores are plotted against predicted pain scores from the final multivariate model for
prediction of follow-up pain. The diagonal line perfect agreement between predicted and observed values is shown for reference
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Limitations
The goal in developing the multivariate predictor models
was to predict pain outcome for individuals. This is a
different objective from the development of a model that
seeks to identify specific predictors that impact the out-
comes. While our models do identify potential predic-
tors of pain (in an exploratory sense), they cannot
reliably claim that variables selected into the models are
determinants of pain and variables not selected into the
models are not. For example, functional disability might
in general be expected to predict pain outcomes. We
found that among single predictors other than pain, this
variable had the strongest correlation with future pain
intensity but it was not included in the multivariate
model because of its correlation with the pain predictors
that were included. In general, the effort of building a
good predictive model does not necessarily lead to reli-
able identification of specific risk factors that truly im-
pact the outcome. The ability to identify these variables
is compromised by the large number of the predictors
and by the correlation among them.
A related issue is the use of p-values for selection of
the specific variables in our results. The univariate p-
values should be interpreted as indicators of variable im-
portance to guide variable selection, not as traditional
hypothesis tests of statistical significance. The confi-
dence intervals and p-values for the coefficients and
odds ratios in the multivariate regression models must
also be viewed as exploratory because both tend to be
over-optimistic in forward variable selection. We consid-
ered only variables with univariate p < 0.05 in the multi-
variate analysis (a univariate filter) to reduce this issue at
least to some extent. This choice may have theoretically
eliminated some true predictors from the multivariate
model. However, reducing the potential for over-fitting
by considering fewer variables in the multivariate selec-
tion process was more desirable in our opinion.
We also would like to emphasize that we did not en-
deavor to create a clinical prediction rule. We did not
have a meaningful clinical comparator such as another
efficacious treatment or no treatment at all. We also did
not have the power to evaluate potential effect modifiers
of intervention including the interaction effect between
treatment alternatives and the final prediction-rule rec-
ommendation [61]. However, the results from our study
data do suggest that it may be difficult to develop a pre-
diction rule to identify patients who might benefit from
SMT for cLBP before they receive treatment.
The principal limitation was that the study was a ran-
domized controlled trial with treatment mostly limited
to SMT of the low back. The baseline models included a
rigorously controlled treatment environment for the first
six weeks. Even though the post-treatment models are
based on the clinical course of cLBP, the influence of
other practice characteristics on patient outcomes not
included in the prediction models cannot be ruled out,
such as full-spine manipulation, physical modalities, su-
pervised exercise, supplements, and advice on posture,
diet, stress management, and other lifestyle and self-care
measures [62]. The observation that decreased future
pain is associated with decreased pain with right lateral
bending, and not left, is questionable and may simply be
an artifact of assessing so many predictors. Pain with
some form of lumbar motion does, however, appear in
all models. External validation in common clinical prac-
tice applied to a variety of patient population is required
to evaluate the robustness of applicability of our models.
Conclusion
Internal validation of prediction models showed that
participant characteristics preceding the start of care
were poor predictors of responders (at least 50 % improve-
ment in pain intensity) and future pain intensity as well.
Variables collected shortly after completion of 6 weeks of
study intervention predicted future pain the best. The
findings from this exercise of model development re-
mind us that creating prediction models is difficult. We
are also reminded of the importance of validating
models. Our results suggest that the simplest model
and the best predictor may be post-treatment pain.
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